Evidence map›Paper›PMID 35451335›Full record

ArticleAIDS research and human retroviruses2022

A Heavy Burden: Preexisting Physical and Psychiatric Comorbidities and Differential Increases Among Male and Female Participants After Initiating Antiretroviral Therapy in the HIV Outpatient Study, 2008-2018.

Ellen Tedaldi, Carl Armon, Jun Li, Jonathan Mahnken, Gina Simoncini, Frank Palella, Kimberly Carlson, Kate Buchacz, HIV Outpatient Study (HOPS) Investigators

Abstract read
In one paragraph

Article in AIDS research and human retroviruses, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Ellen TedaldiDepartment of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
Carl ArmonCerner Corporation, Kansas City, Missouri, USA.ORCID 0000-0003-3789-4485
Jun LiDivision of HIV/AIDS Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Jonathan MahnkenCerner Corporation, Kansas City, Missouri, USA.
Gina SimonciniDepartment of Medicine, Lewis Katz School of Medicine at Temple University, Philadelphia, Pennsylvania, USA.
Frank PalellaDepartment of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Kimberly CarlsonCerner Corporation, Kansas City, Missouri, USA.
Kate BuchaczDivision of HIV/AIDS Prevention and Control, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
HIV Outpatient Study (HOPS) Investigators
Cerner (United States) · USCenters for Disease Control and Prevention · USTemple University · USNorthwestern University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Attention to non-AIDS comorbidities is increasingly important in the HIV care and management in the United States. We sought to assess comorbidities before and after antiretroviral therapy (ART) initiation among persons with HIV (PWH). Using the 2008-2018 HIV Outpatient Study (HOPS) data, we assessed changes in prevalence of physical and psychiatric comorbidities, by sex, among participants initiating ART. Cox proportional hazards models were fit to investigate factors associated with the first documented occurrence of key comorbidities, adjusting for demographics and other covariates, including insurance type, CD4

Indexed as

Anti-HIV AgentsHIV InfectionsAdultCD4 Lymphocyte CountComorbidityFemaleHumansMaleOutpatientsUnited StatesViral LoadAnti-HIV Agentsantiretroviral therapycomorbiditiesgender disparitiesHIV

Identifiers

PMID35451335
PMCPMC12379094
OpenAlexW4224238287

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.